smoking, hyperlipidaemia, and diabetes mellitus are prevalent in end-stage renal disease ( ESRD), but Background. Peritoneal dialysis (PD) patients have a high risk of cardiovascular mortality, which is not cannot fully explain the increased cardiovascular mortality [5]. In the process of atherothrombotic disease, completely explained by conventional risk factors. Other factors related to chronic renal failure and/or endothelial dysfunction is an important initiating event [6 ]. Traditional and non-traditional risk factors can dialysis treatment might lead to endothelial dysfunction, which is associated with an adverse cardiovascular adversely influence endothelial function. One of the new cardiovascular risk factors is hyperhomocysoutcome. One such factor is hyperhomocysteinaemia, which has a high prevalence in PD patients.
Introduction
mined endothelium-dependent vasodilatation in PD patients and examined its relationship with plasma Data of the US Renal Data System show that cardiohomocysteine levels. vascular disease is the major cause of the limited life expectancy in patients on maintenance haemodialysis (HD) and peritoneal dialysis (PD) [1] . PD patients
Subjects and methods
older than 55 years may have an even higher 1-year mortality rate than HD patients [1,2], a difference that has been attributed mainly to an increased risk of Patients death due to infection and cardiovascular disease [1,3], Consecutive patients from our Nephrology department who although an increased prevalence of comorbidity in were on maintenance peritoneal dialysis for at least 3 months mass index, blood pressure, serum total cholesterol, and least 12 h before the measurement. The PD patients were at their designated dry weight and free of clinical signs of fluid number of smokers ( Table 1) . Mean duration of dialysis was 2.9 years (median: 2.4 years; range: 0.5-7.4 years). Renal overload. The brachial artery, just above the elbow, was studied by a vessel wall movement detector system ( Wall diagnoses were hypertensive nephrosclerosis (n=11), chronic glomerulonephritis (n=6), familial polycystic kidney disease Track System, Neurodata). In M-mode, this system measures the arterial diameter with an accuracy of 0.1 to 0.2 mm [24] . (n=3), focal glomerulosclerosis (n=2), diabetic nephropathy, light-chain deposition disease, reflux nephropathy, End diastolic brachial artery diameter was measured at baseline after 15 min of supine rest. Reactive hyperaemia IgA nephropathy, chronic pyelonephritis, Henoch-Schö nlein purpura, and renal failure of unknown origin (all n=1). was induced by release of a blood pressure tourniquet that had been inflated on the forearm for four min at a pressure Eleven patients were on continuous ambulatory peritoneal dialysis (CAPD) and 18 on continuous cyclic peritoneal of 100 mmHg above the systolic blood pressure. The brachial artery diameter was again measured between 45 and 60 s dialysis (CCPD). Adequacy of dialysis was assessed by calculation of weekly total Kt/V and normalized creatinine after the release of the cuff. After 15 min, a second baseline measurement was performed. The final measurement was clearance. Nutritional status of the patients was evaluated by serum albumin and protein catabolic rate (PCR). None performed five min after sublingual administration of 0.4 mg of glyceryl trinitrate (GTN ). Endothelium-dependent andof the patients used folic acid supplementation. All patients used regular dialysis medication, i.e. phosphate binders, independent vasodilatation were expressed as the percentage increase of the brachial artery diameter during reactive erythropoetin, multivitamin B (containing 2 mg vitamin B 6 , but no folic acid or vitamin B 12 ), vitamin C, and vitamin D hyperaemia and after administration of GTN, respectively. Intra-observer within-subjects coefficients of variation for if indicated. Twenty-two patients were hypertensive and used antihypertensives (calcium-antagonists in 15, ACE-inhibitors baseline diameter, endothelium-dependent, and endotheliumindependent vasodilatation are 4.6, 5.5, and 7.7% respectin nine, b-blockers in nine and a-blockers in five). Six patients had a history of cardiovascular disease (stroke in three, ively [23] . myocardial infarction in two, and peripheral artery disease in one). The protocol was approved by the local ethics Statistical methods committee and all participants gave informed consent.
Data are expressed as mean±SEM. Chi-square and twoProcedures sample t tests were used for comparison of variables between groups. Correlations were tested with Pearson's and Blood samples were taken in the fasting state. Serum total Spearman's test as appropriate. A two-tailed P<0.05 was cholesterol was measured enzymatically by the CHOD-PAP considered statistically significant. Univariate and multivarimethod (Boehringer, Mannheim, Germany). In the PD ate regression were used to analyse the determinants of the patients, plasma total (free plus protein bound) homocysteine vascular responses. The multivariate analyses were performed (tHcy) was measured by HPLC with fluorescence detection after taking the PD patients and control subjects together [19] (reference value: 6-15 mmol/l ), and serum albumin and adding a factor 'peritoneal dialysis present or absent' to immunochemically by rate nephelometry (Beckman, Galway, the model. We adjusted for baseline diameter as it is known Ireland; reference value: 34-50 g/l ). Intra-and interassay to affect vascular responses [23] . The diameter after endothecoefficients of variation are 2.1 and 5.1% for tHcy [20] , and lium-dependent or -independent vasodilatation was used as ∏5 and ∏8% for albumin. PCR was calculated according the dependent variable, because relating the percentage to the Randerson method [21] . Body mass index was meas-increase or the absolute increase in diameter to baseline ured as weight (kg)/length (m)2. Blood pressure was meas-diameter predictably yields a strong correlation [25] . ured with an automated device (BP-8800, Colin, Japan). Participants were classified as current or non-smoker.
Endothelium-dependent vasodilatation was assessed non-Results
invasively by determination of the flow-mediated vasodilatation by an investigator not blinded to patient/control subject Endothelium-dependent vasodilatation was significstatus [22, 23] . All subjects refrained from smoking and from antly reduced in the PD patients: 5.7±1.0 vs use of caffeine-containing drinks for at least 10 h before the start of the measurements. Medication was withheld for at 10.4±1.3% in the control group (P=0.004) ( Figure Table 1 . Characteristics of the peritoneal dialysis patients and the control subjects body weight/day. In univariate analyses of the total group, the percentage endothelium-dependent vasodilatation was related only to the mean arterial pressure (r=−0.39; P= 0.003; Figure 2 ) and not to serum total cholesterol level, age, gender or smoking status (Figure 3 ). Multiple regression analyses showed baseline diameter to be the most important predictor of diameter after endothelium-dependent and -independent vasodilatation (standardized regression coefficient (stand. r)= 0.95; P<0.001 and stand. r=0.93; P<0.001). The only other factor that was significantly related to diameter after endothelium-dependent vasodilatation was the presence of peritoneal dialysis (stand. r= −0.13; P=0.014). PD was not related to endotheliumindependent vasodilatation.
In the PD group, uni-and multivariate analyses showed that endothelium-dependent vasodilatation 
Discussion
This is the first study to show that endotheliumdependent vasodilatation is impaired in peritoneal dialysis patients when compared to gender-matched control subjects of comparable age.
Endothelium-dependent vasodilatation in conduit and resistance vessels can be induced by an increase in blood flow which increases shear stress on the endothelium. Nitric oxide mediates this response [26, 27] . Endothelium-mediated vasodilatation in the brachial artery correlates well with the endothelium-dependent Fig. 1 . Endothelium-dependent (flow-mediated ) and -independent response of [28] , and the extent of atherosclerotic (glyceryl trinitrate (GTN )-induced) vasodilatation of the brachial disease in coronary arteries [29] . The impairment in artery in control (C ) subjects and peritoneal dialysis (PD) patients. *P=0.004 vs control subjects. 0% (PD; P=0.19) . The mode of dialysis, therefore, does not seem to have a major influence on the impairment in flow-mediated vasodilatation. Finally, the reduction in endotheliumdependent vasodilatation in both PD and HD patients may, at least partially, be caused by the presence of subclinical atherosclerosis. Considerable coronary artery stenosis has been demonstrated in asymptomatic patients starting dialysis treatment [39] .
endothelium-dependent brachial vasodilatation in the
We conclude that brachial artery endotheliumdependent vasodilatation is markedly reduced in PD patients, which may reflect a generalized increase in atherogenic and thrombogenic properties of the endo- tHcy is elevated in PD patients, but is not related to the reduced endothelium-dependent vasodilatation. Whether such a relation is present in patients with present study therefore may reflect generalized increased atherogenic and thrombogenic endothelial moderate renal failure, who have less markedly elevated tHcy levels, remains to be investigated. properties in PD patients.
We have shown previously that endothelium- 
